Glenmark Pharmaceuticals
GLENMARK.NS
$28.50
Share price
1.03%
Change (1 day)
52.60%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt
Total debt on the balance sheet as of September 2024 : NZ$0.37 Billion
According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is NZ$0.37 Billion. A company’s total debt is the sum of all current and non-current debts.
Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-03-31 | NZ$0.24 B | -72.36% |
| 2023-03-31 | NZ$0.89 B | 19.42% |
| 2022-03-31 | NZ$0.74 B | -22.79% |
| 2021-03-31 | NZ$0.97 B | -15.17% |
| 2020-03-31 | NZ$1.14 B | 21.51% |
| 2019-03-31 | NZ$0.94 B | -4.29% |
| 2018-03-31 | NZ$0.98 B | -5.47% |
| 2017-03-31 | NZ$1.04 B | 19.59% |
| 2016-03-31 | NZ$0.87 B | 7.41% |
| 2015-03-31 | NZ$0.81 B | 28.68% |
| 2014-03-31 | NZ$0.62 B | 3.52% |
| 2013-03-31 | NZ$0.60 B | 13.13% |
| 2012-03-31 | NZ$0.53 B | -13.29% |
| 2011-03-31 | NZ$0.62 B | 5.08% |
| 2010-03-31 | NZ$0.59 B | -19.83% |
| 2009-03-31 | NZ$0.73 B | 132.61% |
| 2008-03-31 | NZ$0.31 B | 4.38% |
| 2007-03-31 | NZ$0.30 B | 12.71% |
| 2006-03-31 | NZ$0.26 B | 91.08% |
| 2005-03-31 | NZ$0.14 B | 254.1% |
| 2004-03-31 | NZ$39.76 M |